Skip to content
  • Login
Therapsil
  • About
    • Take Action
    • About
    • Mission, Vision & Values
    • FAQ
    • News
    • Team
  • Access Psilocybin
    • Patients
    • Doctors
  • Training
    • Intensive Training
    • Prescriber Training
  • Research
    • Project Solace
    • Psilocybin Engagement Report
    • Public Opinion Poll 2021
    • Research Opportunities
    • Reasoning
    • Bibliography
  • Donate
October 19, 2020June 16, 2020

A conversation with Spencer Hawkswell of Therapsil about his organization’s effort to gain psychedelic exemptions for terminally ill patients.

Listen Now

Share this post
fb-share-icon
Tweet
Post navigation
Therapsil
Cancer patients waiting on response from Hon. Health Minister Patty Hajdu
CTV News
Terminally ill Canadians apply for legal access to ‘magic mushrooms’ drug

Links:
Contact Us
Privacy Policy
Our Team
Research

Follow Us:

Newsletter Signup
© 2022 Therapsil